Indo Us Bio-Tech Limited (BOM:541304)
India · Delayed Price · Currency is INR 97.05
-2.45 (-2.46%)
At close: Jun 2, 2026
Indo Us Bio-Tech Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Net Income | 162.67 | 82.41 | 72.4 | 50.63 | 49 |
Depreciation & Amortization | 10.98 | 8 | 8.26 | 4.46 | 2.59 |
Other Amortization | - | - | - | 0.14 | 0.14 |
Loss (Gain) From Sale of Assets | - | 0.04 | - | - | 0.12 |
Provision & Write-off of Bad Debts | 4.68 | -0.6 | - | - | - |
Other Operating Activities | 13.42 | 17.55 | 10.23 | 10.4 | 0.37 |
Change in Accounts Receivable | 35.76 | 57.57 | -42.01 | 41.59 | -37.29 |
Change in Inventory | -189.51 | -248.22 | -35.56 | -114.77 | -27.32 |
Change in Accounts Payable | -32.26 | 29.91 | -7.61 | 33.06 | 8.1 |
Change in Other Net Operating Assets | 8.45 | 75.55 | -0.45 | 1.51 | 5.86 |
Operating Cash Flow | 14.19 | 22.21 | 5.26 | 27.03 | 1.58 |
Operating Cash Flow Growth | -36.10% | 322.52% | -80.55% | 1612.03% | - |
Capital Expenditures | -8.62 | -26.1 | -18.23 | -39.67 | -19.53 |
Sale of Property, Plant & Equipment | - | - | - | - | 0.1 |
Investment in Securities | - | - | 0.1 | - | - |
Other Investing Activities | 0.7 | 0.83 | 1.25 | 0.03 | 0.02 |
Investing Cash Flow | -7.92 | -25.28 | -66.74 | -54.42 | -17.79 |
Short-Term Debt Issued | 3.8 | 16.28 | 7.88 | 9.92 | 1.17 |
Long-Term Debt Issued | 1.32 | 10.97 | - | 2.8 | 26.03 |
Total Debt Issued | 5.12 | 27.25 | 7.88 | 12.72 | 27.2 |
Long-Term Debt Repaid | - | - | -16.91 | - | - |
Total Debt Repaid | - | - | -16.91 | - | - |
Net Debt Issued (Repaid) | 5.12 | 27.25 | -9.03 | 12.72 | 27.2 |
Issuance of Common Stock | - | - | 83.76 | 27.09 | - |
Common Dividends Paid | -5.01 | - | - | -1.52 | - |
Other Financing Activities | -14.88 | -15.1 | -11.84 | -11.75 | -11.65 |
Financing Cash Flow | -14.77 | 12.15 | 62.89 | 26.54 | 15.55 |
Miscellaneous Cash Flow Adjustments | - | - | 0 | - | -0 |
Net Cash Flow | -8.51 | 9.09 | 1.41 | -0.85 | -0.66 |
Free Cash Flow | 5.57 | -3.89 | -12.97 | -12.64 | -17.95 |
Free Cash Flow Margin | 0.54% | -0.53% | -2.10% | -2.52% | -4.48% |
Free Cash Flow Per Share | 0.28 | -0.19 | -0.67 | -1.03 | -1.23 |
Cash Interest Paid | 14.88 | 15.1 | 11.84 | 11.76 | 11.66 |
Cash Income Tax Paid | 3.52 | 3.11 | 3.15 | 3.87 | 1.38 |
Levered Free Cash Flow | -68.33 | -36.06 | -100.53 | -157.48 | -44.53 |
Unlevered Free Cash Flow | -59.35 | -27.25 | -93.51 | -150.32 | -37.52 |
Change in Working Capital | -177.56 | -85.19 | -85.63 | -38.61 | -50.65 |